pipette
ESEspañol

A dual-targeting lipid nanoparticle delivery system for precision phage therapy against multidrug-resistant Gram-negative bacteria

Zhijun Chen, Wenjun Hu, Hui Fan Nie, Yifan Zhang, Weilin Tang, Zhihe Yu, Jiani Cao, Xunying Zhu, Xinrong Liu, Mingqian Chen, Udi Qimron, Andrij Pich, Huan Peng, Jianfeng Liu

Peer-reviewed journalBold claims, read criticallyClaims a big stepReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
In murine models of Pseudomonas aeruginosa infection, AbLCP achieved superior bacterial clearance and up to 10 3 -fold reduction in bacterial burden at a 10 3 -fold lower effective dose than free polymyxin B, with 67-fold selective accumulation at infection sites, and attenuated systemic inflammation and preservation of gut microbiota.

Appeared: Sunday, November 1. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aeh7105